Analysis PreveCeutical Medical Inc. (PRVCF)
5/31/2024
Analysis of PreveCeutical Medical Inc. (PRVCF)
PreveCeutical Medical Inc. (PRVCF) has shown some interesting price movements and technical indicators in the recent days:1. Price Movement:
- The closing price has been fluctuating between 0.01470 and 0.01950 over the past few days.
- The stock closed at 0.01950 on the most recent trading day, showing an upward trend.
2. Relative Strength Index (RSI):
- The RSI indicator has been hovering around 50-60, indicating a moderate level of buying momentum.
- The RSI value on the latest trading day was 59.69, suggesting the stock is neither overbought nor oversold.
3. Moving Averages:
- The Simple Moving Average (SMA) and Exponential Moving Average (EMA) have been relatively close to each other, indicating a stable trend.
- The Weighted Moving Average (WMA) has also been consistent with the SMA and EMA.
4. MACD Indicator:
- The MACD line has been positive, indicating a bullish signal.
- The MACD histogram has shown an increasing trend, suggesting a strengthening bullish momentum.
Overall, based on the price movements, RSI, moving averages, and MACD indicator, PreveCeutical Medical Inc. seems to be in a positive trend with potential for further upward movement. However, it is important to consider other fundamental factors and conduct a more in-depth analysis before making any investment decisions.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a company. Here are the key points:1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320. Levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a quarterly basis is $67,150,000,128. Total debt on a quarterly basis is $104,590,000,128. Current ratio is 1.037. Book value per share is $4.837. Total cash per share is $4.379. Total debt to equity ratio is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000. Revenue TTM is $381,623,009,280. Diluted EPS TTM is $6.43. Gross profit TTM is $169,148,000,000. Revenue per share TTM is $24.537. Net income to common TTM is $100,389,003,264. Quarterly revenue growth is -4.3%. Quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets**: Return on assets TTM is 22.073999%.
- **Return on Equity**: Return on equity TTM is 147.25%.
- **Fiscal Year Ends**: The fiscal year ends on September 30, 2023.
- **Most Recent Quarter**: The most recent quarter is March 31, 2024.
2. **Stock Statistics**:
- **Short Ratio**: Short ratio is 1.53.
- **Shares Information**: Float shares are 15,308,320,742. Shares short are 99,287,450. Average 10-day volume is 46,860,048. Average 90-day volume is 57,498,254. Shares outstanding are 15,334,099,968. Percentage held by insiders is 5.22%. Percentage held by institutions is 57.589%. Short percent of shares outstanding is 0.65%.
3. **Valuations Metrics**:
- **P/E Ratios**: Forward P/E ratio is 26.319502. Trailing P/E ratio is 29.59409.
- **Enterprise Value**: Enterprise value is $2,950,762,332,160.
- **Price to Book**: Price to book ratio on a quarterly basis is 39.3405.
- **Price to Sales**: Price to sales TTM is 7.646095.
- **Enterprise to EBITDA**: Enterprise to EBITDA ratio is 22.763.
- **Enterprise to Revenue**: Enterprise to revenue ratio is 7.732.
- **Market Capitalization**: Market capitalization is $2,917,925,650,432.
4. **Stock Price Summary**:
- **Beta**: Beta is 1.264.
- **Moving Averages**: 50-day moving average is $176.2646. 200-day moving average is $181.0429.
- **52-Week Range**: 52-week low is $164.08. 52-week high is $199.62. 52-week change is 6.853%.
5. **Dividends and Splits**:
- **Dividend Information**: Payout ratio is 14.93%. Dividend date is May 16, 2024. Ex-dividend date is May 10, 2024. Last split date was August 31, 2020, with a 4-for-1 split. Forward annual dividend rate is $1. 5-year average dividend yield is 0.73%. Forward annual dividend yield is 0.5255%. Trailing annual dividend rate is $0.97. Trailing annual dividend yield is 0.5097%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential challenge in managing production or procurement costs.
3. The gross profit margin has remained relatively stable over the years, indicating that the company has been able to maintain profitability despite the increase in sales and cost of goods sold.
4. Operating income has also shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020, indicating efficient management of operating expenses.
5. Net income has been increasing over the years, reflecting the company's ability to generate profits after accounting for all expenses and taxes.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased, indicating that the company's profitability is being distributed among shareholders.
7. The company has been able to generate consistent EBITDA, EBIT, and net income from its core operations, which is a positive sign for investors.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance/payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability in operations and variability in financing and investing decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows growth compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This indicates an increase from the EPS of $1.35 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, showing growth in both the quarterly and annual results over the specified periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be positive.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, there is a wide range of estimates, from a low of $164 to a high of $250. The current price of the security is $191.57, which is below both the average and median forecasted prices.
MACD of PRVCF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
